LifePoint Health Inc (LPNT) Receives $65.33 Consensus Target Price from Analysts

LifePoint Health Inc (LPNT) Receives $65.33 Consensus Target Price from Analysts

LifePoint Health Inc (NASDAQ:LPNT) has earned a consensus recommendation of “Hold” from the seventeen research firms that are covering the firm. Three investment analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and five have given a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $65.33.

Several research firms have weighed in on LPNT. Zacks Investment Research raised LifePoint Health from a “sell” rating to a “hold” rating in a research report on Wednesday, February 22nd. Cantor Fitzgerald reissued a “neutral” rating on shares of LifePoint Health in a research report on Tuesday, February 21st. Mizuho raised their price target on LifePoint Health from $50.00 to $57.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 21st. TheStreet raised LifePoint Health from a “c+” rating to a “b-” rating in a research report on Monday, March 13th. Finally, Piper Jaffray Companies began coverage on LifePoint Health in a research report on Wednesday, January 4th. They issued a “neutral” rating and a $62.00 price objective for the company.

LifePoint Health (NASDAQ:LPNT) opened at 62.10 on Thursday. The company’s 50-day moving average price is $62.56 and its 200 day moving average price is $59.29. The firm has a market cap of $2.48 billion, a price-to-earnings ratio of 22.02 and a beta of 0.87. LifePoint Health has a 1-year low of $50.60 and a 1-year high of $75.70.

LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Friday, February 17th. The company reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.02. The company earned $1.61 billion during the quarter, compared to the consensus estimate of $1.63 billion. LifePoint Health had a return on equity of 7.02% and a net margin of 1.93%. LifePoint Health’s revenue was up 17.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.11 earnings per share. On average, equities analysts expect that LifePoint Health will post $4.18 earnings per share for the current fiscal year.

In related news, insider David M. Dill sold 1,200 shares of LifePoint Health stock in a transaction on Friday, March 10th. The stock was sold at an average price of $65.00, for a total value of $78,000.00. Following the transaction, the insider now owns 208,773 shares in the company, valued at $13,570,245. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider David M. Dill sold 18,800 shares of LifePoint Health stock in a transaction on Thursday, March 16th. The shares were sold at an average price of $62.22, for a total value of $1,169,736.00. Following the completion of the transaction, the insider now owns 207,873 shares in the company, valued at approximately $12,933,858.06. The disclosure for this sale can be found here. Insiders sold 46,667 shares of company stock worth $2,982,409 in the last quarter. 7.28% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Victory Capital Management Inc. boosted its position in shares of LifePoint Health by 65.2% in the third quarter. Victory Capital Management Inc. now owns 1,692 shares of the company’s stock worth $100,000 after buying an additional 668 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in shares of LifePoint Health by 1,006.8% in the third quarter. Tower Research Capital LLC TRC now owns 2,756 shares of the company’s stock worth $163,000 after buying an additional 2,507 shares during the last quarter. ETRADE Capital Management LLC purchased a new position in shares of LifePoint Health during the third quarter worth $257,000. Eqis Capital Management Inc. purchased a new position in shares of LifePoint Health during the third quarter worth $299,000. Finally, First Citizens Bank & Trust Co. boosted its position in shares of LifePoint Health by 1.7% in the third quarter. First Citizens Bank & Trust Co. now owns 5,233 shares of the company’s stock worth $310,000 after buying an additional 88 shares during the last quarter. Hedge funds and other institutional investors own 99.88% of the company’s stock.

LifePoint Health Company Profile

LifePoint Health, Inc, formerly LifePoint Hospitals, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. The Company operates through healthcare services segment. The Company operates over 70 hospital campuses in over 20 states, having a total of over 8,240 licensed beds.

Related posts

Leave a Comment